Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI).

Troels Yndigegn Bertil Lindahl Joakim AlfredssonJocelyne BenatarLisa BrandinDavid ErlingeUrban HaagaClaes HeldPelle JohanssonPatric KarlströmThomas KellerthToomas Marandi Katarina Mars Annica Ravn FischerJohan SundströmOllie ÖstlundRobin Hofmann Tomas Jernberg

Published in: European heart journal. Cardiovascular pharmacotherapy (2022)

The results from REDUCE-AMI will add important evidence regarding the effect of beta-blockers in patients with MI and preserved EF and may change guidelines and clinical practice.

Keyphrases

acute myocardial infarction
clinical practice
angiotensin converting enzyme
percutaneous coronary intervention
left ventricular
double blind
open label
clinical trial
placebo controlled
phase iii
angiotensin ii
phase ii
acute coronary syndrome